NCT01268956

Brief Summary

Correlation of circulating lymphatic endothelial progenitor cells with lymph node metastasis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 4, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
Last Updated

January 4, 2011

Status Verified

December 1, 2010

Enrollment Period

5 months

First QC Date

January 3, 2011

Last Update Submit

January 3, 2011

Conditions

Ovarian Cancer

Study Arms (2)

Lymphatic progenitor cell

Circulating lymphatic progenitor cell

Control

healthy people

Eligibility Criteria

Age15 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ovarian cancer patients

You may qualify if:

  • ovarian cancer patients diagnosed by pathologic examination

You may not qualify if:

  • other malignant disease inflammatory disease untreated diabetic and hypertension chronic renal failure rheumatoid arthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics & Gynecology, Southwest Hospital

Chongqing, Sichuan, 400038, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood serum

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Officials

  • Pianyifan pianyifan, Doctor

    Southwest Hospital, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Huiling Qiu Zhiqing Liang, Doctor

CONTACT

86-23-68754813zhi.lzliang@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 3, 2011

First Posted

January 4, 2011

Study Start

January 1, 2011

Primary Completion

June 1, 2011

Study Completion

September 1, 2011

Last Updated

January 4, 2011

Record last verified: 2010-12

Locations

CN(1)